Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data (Q32065085)

6 July 2017

1 reference

title

Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data (English)

1 reference

6 July 2017

Lanza FL

1

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Medicine

6 July 2017

published in

1 reference

6 July 2017

volume

104

1 reference

6 July 2017

issue

3A

1 reference

6 July 2017

page(s)

75S-78S; discussion 79S-80S

1 reference

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury. Effect of scoring method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900216-7

10.1016/S0002-9343(97)00216-7

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference